Bova S, Trevisi L, Debetto P, Cima L, Furnari M, Luciani S
Br J Pharmacol. 1996; 117(6):1041-6.
PMID: 8882594
PMC: 1909795.
DOI: 10.1111/j.1476-5381.1996.tb16694.x.
Torfgard K, Ahlner J
Cardiovasc Drugs Ther. 1994; 8(5):701-17.
PMID: 7873467
DOI: 10.1007/BF00877117.
Sorkin E, Brogden R, Romankiewicz J
Drugs. 1984; 27(1):45-80.
PMID: 6420139
DOI: 10.2165/00003495-198427010-00003.
Spies C, Schultz K, Schultz G
Naunyn Schmiedebergs Arch Pharmacol. 1980; 311(1):71-7.
PMID: 6245377
DOI: 10.1007/BF00500305.
Evans P
J Physiol. 1984; 348:307-24.
PMID: 6201609
PMC: 1199404.
DOI: 10.1113/jphysiol.1984.sp015112.
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta.
Miller R, Mony M, Schini V, Schoeffter P, STOCLET J
Br J Pharmacol. 1984; 83(4):903-8.
PMID: 6151414
PMC: 1986987.
DOI: 10.1111/j.1476-5381.1984.tb16530.x.
cGMP and cAMP inhibit tension development in skinned coronary arteries.
Pfitzer G, Hofmann F, DiSalvo J, Ruegg J
Pflugers Arch. 1984; 401(3):277-80.
PMID: 6089100
DOI: 10.1007/BF00582596.
Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein.
Quast U
Br J Pharmacol. 1987; 91(3):569-78.
PMID: 3038244
PMC: 1853539.
DOI: 10.1111/j.1476-5381.1987.tb11250.x.
Role of cyclic GMP in the modulation by endothelium of the adrenolytic action of prazosin in the rat isolated aorta.
Alosachie I, GODFRAIND T
Br J Pharmacol. 1986; 89(3):525-32.
PMID: 3026546
PMC: 1917145.
DOI: 10.1111/j.1476-5381.1986.tb11152.x.
Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction.
Fujimoto K, Sakai A, Yoshikawa S, Shinozaki S, Matsuzawa Y, Kubo K
Lung. 1990; 168(6):333-43.
PMID: 2177815
DOI: 10.1007/BF02719710.
Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils.
Wenzel-Seifert K, Ervens J, Seifert R
Naunyn Schmiedebergs Arch Pharmacol. 1991; 344(4):396-402.
PMID: 1722562
DOI: 10.1007/BF00172578.
Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate.
Ervens J, Schultz G, Seifert R
Naunyn Schmiedebergs Arch Pharmacol. 1991; 343(4):370-6.
PMID: 1649410
DOI: 10.1007/BF00179041.
Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
Renowden S, Edwards D, Griffith T
Br J Pharmacol. 1992; 106(2):348-53.
PMID: 1327377
PMC: 1907486.
DOI: 10.1111/j.1476-5381.1992.tb14339.x.
Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle.
Kukovetz W, Holzmann S, Wurm A, Poch G
Naunyn Schmiedebergs Arch Pharmacol. 1979; 310(2):129-38.
PMID: 231208
DOI: 10.1007/BF00500277.
The influence of 8-Br 3', 5'-cyclic nucleotide analogs and of inhibitors of 3', 5'-cyclic nucleotide phosphodiesterase, on noradrenaline secretion and neuromuscular transmission in guinea-pig vas deferens.
Stjarne L, Bartfai T, Alberts P
Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(2):99-105.
PMID: 228209
DOI: 10.1007/BF00499050.